This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to encourage drug ...

Akums Drugs and Pharmaceuticals reported a 15% increase in adjusted profit after tax, reaching Rs 66.3 crore for the quarter ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

TGCHE and BDMAI sign MoU to bridge academia-pharma industry skill gap, aligning education with industry needs for workforce development.

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...